Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

NCT06005792 ·Status: TERMINATED ·Phase: PHASE1

A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06672393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis

NCT06620692 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

NCT03337022 ·Status: COMPLETED ·Phase: PHASE1

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

NCT01708603 ·Status: TERMINATED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

NCT02173301 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis

NCT04908514 ·Status: COMPLETED ·Phase: PHASE2

A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.

NCT05965089 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

NCT07051538 ·Status: COMPLETED ·Phase: PHASE1

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT02223039 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study in Participants With Moderate to Severe Psoriasis

NCT01474512 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

NCT06807424 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

NCT06926582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis

NCT05223868 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT01072383 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis

NCT02776033 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03358290 ·Status: TERMINATED ·Phase: PHASE2

A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab

NCT02173392 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06077331 ·Status: RECRUITING ·Phase: PHASE2

Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris

NCT03342573 ·Status: COMPLETED ·Phase: PHASE1

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT04839016 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects

NCT01708629 ·Status: TERMINATED ·Phase: PHASE3

Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

NCT00604682 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

NCT04121143 ·Status: SUSPENDED ·Phase: PHASE2

A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis

NCT00106834 ·Status: COMPLETED ·Phase: PHASE3